In the next step, we stimulated stably CXCL16 expressing LOX melanoma cells (LOX-CXCL16) with recombinant CXCR6 and observed again an activation of ERK1/2 (Figure 3A, upper part). The gene discussed is CXCR6; the disease is melanoma.